Impact of maternal endothelial nitric oxide synthase gene polymorphisms on blood pressure, protein excretion and fetal outcome in pregnancy

Journal of Human Hypertension

Volumn 22, Issue 9, 2008, Pages 641-647

  Hocher, B ^a   Chen, Y P ^a,b   Hugle S ^a   Repey, J ^a   Krause, K ^a   Slowinski, T ^c   Godes, M ^a   Schaeffeler, E ^d,e   Guthmann, F ^c   Wauer, R ^c   Halle, H ^c   Gossing, G ^c   Pfab, T ^a,b  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^b JINAN UNIVERSITY   (China)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANINE; THYMINE;

ADULT; ALLELE; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; CAUCASIAN; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS GROWTH; FETUS OUTCOME; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MARKER GENE; MATERNAL HYPERTENSION; NUCLEIC ACID BASE SUBSTITUTION; PERIPHERAL EDEMA; POPULATION BASED CASE CONTROL STUDY; PREECLAMPSIA; PROTEIN DEPLETION; PROTEIN SECRETION; RISK FACTOR;

ADULT; BLOOD PRESSURE; FEMALE; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROTEINURIA;

EID: 50449096599     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.34     Document Type: Article

References (43)

1. Weiner CP, Knowles RG, Moncada S. Induction of nitric oxide synthases early in pregnancy. Am J Obstet Gynecol 1994; 171: 838-843.
2. Podjarny E, Baylis C, Losonczy G. Animal models of preeclampsia. Semin Perinatol 1999; 23: 2-13.
3. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol 1997; 272: R441-R463.
4. Williams DJ, Vallance PJ, Neild GH, Spencer JA, Imms FJ. Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol 1997; 272: H748-H752.
5. Brennecke SP, Gude NM, Di Iulio JL, King RG. Reduction of placental nitric oxide synthase activity in pre-eclampsia. Clin Sci (Lond) 1997; 93: 51-55.
6. Kim YJ, Park HS, Lee HY, Ha EH, Suh SH, Oh SK et al. Reduced L-arginine level and decreased placental eNOS activity in preeclampsia. Placenta 2006; 27: 438-444.
7. Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW et al. The Glu298Asp polymorphisin of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002; 20: 2023-2027.
8. Savvidou MD, Vallance PJ, Nicolaides KH, Hingorani AD. Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension 2001; 38: 1289-1293.
9. Fatini C, Sticchi E, Gensini F, Genuardi M, Tondi F, Gensini GF et al. Endothelial nitric oxide synthase gene influences the risk of pre-eclampsia, the recurrence of negative pregnancy events, and the maternal-fetal flow. J Hypertens 2006; 24: 1823-1829.
10. Miyamoto Y, Saito Y, Nakayama M, Shimasaki Y, Yoshimura T, Yoshimura M et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T→ C mutation associated with coronary spastic angina. Hum Mol Genet 2000; 9 2629-2637.
11. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H et al. T-786→ C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-2870.
12. Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997; 17: 3147-3153.
13. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998; 245: 190-193.
14. Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: A HuGE review. Am J Epidemiol 2006; 164 921-935.
15. Serrano NC, Casas JP, Diaz LA, Paez C, Mesa CM, Cifuentes R et al. Endothelial NO synthase genotype and risk of preeclampsia: A multicenter case-control study. Hypertension 2004; 44: 702-707.
16. Hakli T, Romppanen EL, Hiltunen M, Helisalmi S, Punnonen K, Heinonen S. Endothelial nitric oxide synthase polymorphism in preeclampsia. J Soc Gynecol Investig 2003; 10: 154-157.
17. Yoshimura T, Yoshimura M, Tabata A, Shimasaki Y, Nakayama M, Miyamoto Y et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Investig 2000; 7: 238-241.
18. Kobashi G, Yamada H, Ohta K, Kato E, Ebina Y, Fujimoto S. Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy. Am J Med Genet 2001; 103: 241-244.
19. Yoshimura T, Chowdhury FA, Yoshimura M, Okamura H. Genetic and environmental contributions to severe preeclampsia: Lack of association with the endothelial nitric oxide synthase Glu298Asp variant in a developing country. Gynecol Obstet Invest 2003; 56: 10-13.
20. Seremak-Mrozikiewicz A, Drews K, Mrozikiewicz PM. The -786T/C polymorphism of the endothelial nitric oxide synthase gene in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2007; doi:10.1016/j.ejogrb.2007.02.008.
21. Pfab T, Chen YP, Slowinski T, Richter CM, Godes M, Arck PC et al. Impact of genes related to immune tolerance and inflammation (tumour necrosis factor-alpha, interleukin-6) on blood pressure, protein excretion and oedema in pregnancy. J Hypertens 2005; 23: 2187-2191.
22. Pfab T, Stirnberg B, Sohn A, Krause K, Slowinski T, Godes M et al. Impact of maternal angiotensinogen M235T polymorphism and angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure, protein excretion and fetal outcome in pregnancy. J Hypertens 2007; 25: 1255-1261.
23. Hocher B, Slowinski T, Bauer C, Halle H. The advanced fetal programming hypothesis. Nephrol Dial Transplant 2001; 16: 1298-1299.
24. Hocher B, Slowinski T, Stolze T, Pleschka A, Neumayer HH, Halle H. Association of maternal G protein beta3 subunit 825T allele with low birthweight. Lancet 2000; 355: 1241-1242.
25. Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002; 287: 195-202.
26. Vatish M, Randeva HS, Grammatopoulos DK. Hormonal regulation of placental nitric oxide and pathogenesis of pre-eclampsia. Trends Mol Med 2006; 12: 223-233.
27. National High Blood Pressure Education Program Working Group. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
28. Hocher B, Slowinski I, Hauser I, Vetter B, Fritsche L, Bachert D et al. Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients. Thromb Haemost 2002; 87: 194-198.
29. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68 978-989.
30. Gardemann A, Lohre J, Cayci S, Katz N, Tillmanns H, Haberbosch W. The T allele of the missense Glu(298)Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile. Atherosclerosis 2002; 160: 167-175.
31. Alvarez R, Gonzalez P, Batalla A, Reguero JR, Iglesias-Cubero G, Hevia S et al. Association between the NOS3 (-786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide 2001; 5: 343-348.
32. Yu CK, Casas JP, Savvidou MD, Sahemey MK, Nicolaides KH, Hingorani AD. Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: A case-control study and a meta-analysis. BMC Pregnancy Childbirth 2006; 6: 7.
33. Medica I, Kastrin A, Peterlin B. Genetic polymorphisms in vasoactive genes and preeclampsia: A meta-analysis. Eur J Obstet Gynecol Reprod Biol 2007; 131: 115-126.
34. Tempfer CB, Dorman K, Deter RL, O'Brien WE, Gregg AR. An endothelial nitric oxide synthase gene polymorphism is associated with preeclampsia. Hypertens Pregnancy 2001; 20: 107-118.
35. Diket AL, Pierce MR, Munshi UK, Voelker CA, Eloby-Childress S, Greenberg SS et al. Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol 1994; 171: 1243-1250.
36. Hefler LA, Reyes CA, O'Brien WE, Gregg AR. Perinatal development of endothelial nitric oxide synthase-deficient mice. Biol Reprod 2001; 64: 666-673.
37. Schiessl B, Strasburger C, Bidlingmaier M, Mylonas I, Jeschke U, Kainer F et al. Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Arch Gynecol Obstet 2006; 274: 150-154.
38. Xiao XM, Li LP. L-Arginine treatment for asymmetric fetal growth restriction. Int J Gynaecol Obstet 2005; 88: 15-18.
39. Sieroszewski P, Suzin J, Karowicz-Bilinska A. Ultrasound evaluation of intrauterine growth restriction the,rapy by a nitric oxide donor (L-arginine). J Matern Fetal Neonatal Med 2004; 15: 363-366.
40. Huber A, Grimm C, Jirecek S, Heim K, Zeillinger R, Husslein P et al. Polymorphisms of the Nos3 gene and unexplained late intrauterine fetal death. Eur J Obstet Gynecol Reprod Biol 2005; 122: 151-155.
41. Tiboni GM, Giampietro F, Di Giulio C. The nitric oxide synthesis inhibitor Nomega-nitro-L-arginine methyl ester (L-NAME) causes limb defects in mouse fetuses: Protective effect of acute hyperoxia. Pediatr Res 2003; 54: 69-76.
42. Gregg AR, Schauer A, Shi O, Liu Z, Lee CG, O'Brien WE. Limb reduction defects in endothelial nitric oxide synthase-deficient mice. Am J Physiol 1998; 275: H2319-H2324.
43. Shaw GM, Iovannisci DM, Yan W, Finnell RH, Carmichael SL, Cheng S et al. Endothelial nitric oxide synthase (NOS3) genetic variants, maternal smoking, vitamin use, and risk of human orofacial clefts. Am J Epidemiol 2005; 162: 1207-1214.